After the US FDA rejected Merck's cholesterol drug Chordaptive and disappointing sales of Vytorin, Merck is slashing 1,200 jobs - mainly from its salesforce.
« Indian CRO ( Clinical Research Outsourcing ) Industry " Panel Requests Tighter Rules Against Clinical Trials" | Main | Pharma's Failure to Connect at Philadelphia Airport »
Tuesday, May 06, 2008
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e54fa3e7ea883400e5521122b48833
Listed below are links to weblogs that reference Merck is Cutting 1200 Jobs...:
Verify your Comment
Previewing your Comment
This is only a preview. Your comment has not yet been posted.
Your comment could not be posted. Error type:
Your comment has been posted. Post another comment
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Sites I Visit the Most!
Recent Posts
- MPM Capital Makes First Investment in Indian CRO Sai Advantium
- Pharma's Failure to Connect at Philadelphia Airport
- Merck is Cutting 1200 Jobs...
- Indian CRO ( Clinical Research Outsourcing ) Industry " Panel Requests Tighter Rules Against Clinical Trials"
- Told You So: Indian Pharma's M&A Frenzy Continues
- Pharma News Analysis Referenced in BioSpectrum
- Outsourcing: Mumbai or Nebraska?
- Pharma CEOs & Executives Afraid
- Back from Hiatus
- Troubles for Pfizer's Lipitor Ad & An Inventor/Model: Pharmaceutical Industry Under Attack
Categories
- China
- Clinical Trials
- Conferences, Events, Trade shows
- Consultants, Advisors
- Consumers, Direct-to-Consumers
- Current Affairs
- Disease Management
- Europe
- FDA, Regulations & Governmet
- Fun, Silly
- Generics
- India
- IT
- Leaders, CEOs, Executives
- Licensing
- M&A ( Mergers Acquisitions )
- New Business Models
- Outsourcing & Offshoring
- PharmaNewsAnalysis
- Presentations
- Proximare
- R&D
- Retailers, Wholesalers & Distributors
- Sales & Marketing
- Strategy
- Supply Chain
- USA
Comments